It is also noteworthy that basal levels of cortisol and levels of cortisol following corticotropin-releasing hormone (CRH) stimulation vary according to disease subtypes and severity of MS for reasons which are not fully understood [256]. This evidence concerns the gene CRH and myeloid sarcoma.